Amended recombinant cells (ARCs™): An economical and surprisingly effective production and delivery vehicle for recombinant bovine IFN-γ

Journal of Controlled Release

Volumn 107, Issue 2, 2005, Pages 189-202

  Gaertner, Frank H ^a   Babiuk, Lorne A ^b   Van Moorlehem, Elaine A ^b   Beskorwayne, Terry K ^b   Lee, Stacey L ^c   Shutter, Robert W ^c   Armstrong, Janna M ^d   Griebel, Philip J ^b  

^a Vaccine and Infectious Disease Organization ^*  (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c DOW CHEMICAL COMPANY   (United States)

^d DOW AGROSCIENCES LLC   (United States)

Author keywords

Adjuvant; Bovine; Cytokine delivery; Interferon gamma; Recombinant bacterial vector; Sustained release

Indexed keywords

CELL CULTURE; CYTOLOGY; GAMMA RAYS; PROTEINS;

ADJUVANT; BOVINE; CYTOKINE DELIVERY; INTERFERON-GAMMA; RECOMBINANT BACTERIAL VECTOR; SUSTAINED RELEASE;

CELLS;

ADJUVANT; RECOMBINANT BGI PROTEIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL WALL; CATTLE; CELL CULTURE; CONTROLLED STUDY; COW; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; ENCAPSULATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS FLUORESCENS; SUSTAINED DRUG RELEASE;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CATTLE; CELL WALL; CLINICAL TRIALS; CLONING, MOLECULAR; CYTOKINES; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENES, MHC CLASS II; HAPTOGLOBINS; INTERFERON-GAMMA, RECOMBINANT; MALE; PLAQUE ASSAY; PSEUDOMONAS AERUGINOSA; STERILIZATION; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 24944545669     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.06.008     Document Type: Article

References (45)

1. S. Huang, W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet Immune response in mice that lack the interferon-gamma receptor Science 259 5102 1993 1742 1745
2. E. Jouanguy, S. Lamhamedi-Cherradi, D. Lammas, S.E. Dorman, M.C. Fondaneche, S. Dupuis, R. Doffinger, F. Altare, J. Girdlestone, J.F. Emile, H. Ducoulombier, D. Edgar, J. Clarke, V.A. Oxelius, M. Brai, V. Novelli, K. Heyne, A. Fischer, S.M. Holland, D.S. Kumararatne, R.D. Schreiber, and J.L. Casanova A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection Nat. Genet. 21 4 1999 370 378
3. A. Isaacs, and J. Lindermann Virus interference: I. The interferon Proc. R. Soc. Lond., B Biol. Sci. 147 1957 258 267
4. K. Schroder, P.J. Hertzog, T. Ravasi, and D.A. Hume Interferon-γ: an overview of signals, mechanisms, and functions J. Leukoc. Biol. 75 2 2004 163 189
5. S. Tanaka, T. Oshima, K. Ohsuye, T. Ono, A. Mizono, A. Ueno, H. Nakazato, M. Tsujimoto, N. Higashi, and T. Noguchi Expression in Escherichia coli of chemically synthesized gene for the human immune interferon Nucleic Acids Res. 11 6 1983 1707 1723
6. D.P. Cerretti, K. McKereghan, A. Larsen, D. Cosman, S. Gillis, and P.E.. Baker Cloning, sequence, and expression of bovine interferon-γ J. Immunol. 136 12 1986 4561 4564
7. K. Hübel, D.C. Dale, and W.C. Liles Therapeutic use of cytokines to modulate phagocytic function of the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor and interferon-γ J. Infect. Dis. 185 10 2002 1490 1501
8. G. Raghu, K.K. Brown, W.Z. Bradford, K. Starko, P.W. Noble, D.A. Schwartz, and T.E. King Jr. A placebo-controlled trial of interferon gamma-1β in patients with idiopathic pulmonary fibrosis N. Engl. J. Med. 350 2 2004 125 133
9. U.R. Kleeberg, S. Suciu, E.B. Brocker, D.J. Ruiter, C. Chartier, D. Lienard, J. Marsden, D. Schadendorf, and A.M. Eggermont Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness > 3 mm) or regional lymph node metastasis Eur. J. Cancer 40 3 2004 390 402
10. T.T. Kuberski, R.J. Servi, and P.J. Rubin Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma Clin. Infect. Dis. 38 6 2004 910 912
11. I.H. Kishko, and M.I. Vasylenko The use of gamma-interferon for the prevention and treatment of infectious diseases in piglets and calves Mikrobiol. Z. 61 1999 28 32
12. H. Bielefeldt Ohmann, and L.A. Babiuk In vitro and systemic effects of recombinant bovine interferons on natural cell-mediated cytotoxicity in healthy and bovine herpesvirus-1-infected cattle J. Interf. Res. 5 1985 551 564
13. L.M. Sordillo, and L.A. Babiuk Controlling acute Escherichia coli mastitis during the periparturient period with recombinant bovine interferon gamma Vet. Microbiol. 28 1991 189 198
14. J.A. Roth, and D.E. Frank Recombinant bovine interferon-gamma as an immunomodulator in dexamethasone-treated and nontreated cattle J. Interf. Res. 9 1 1989 143 151
15. K.P. Anderson, E.H. Fennie, and Y. Yilma Enhancement of a secondary antibody response to vesicular stomatitis virus "G" protein by IFN-γ treatment at primary immunization J. Immunol. 140 10 1988 3599 3604
16. T. Yilma, S. Owens, E.H. Fennie, and K.P. Anderson Enhancement of primary and secondary immune responses by interferon-gamma Adv. Exp. Med. Biol. 251 1989 145 152
17. C. Raggo, M. Habermehl, L.A. Babiuk, and P. Griebel In vivo effects of a recombinant bovine herpesvirus-1 vector expressing bovine interferon-gamma J. Gen. Virol. 81 Pt 11 2000 2665 2673
18. P.J. Murray, A. Aldovini, and R.A. Young Manipulation and potentiation of antimicrobial immunity using recombinant bacilli Calmette-Guerin strains that secrete cytokines Proc. Natl. Acad. Sci. U. S. A. 93 2 1996 934 939
19. M.J. Carrier, S.N. Chatfield, G. Dougan, U.T. Nowicka, D. O'Callaghan, J.E. Beesley, S. Milano, E. Cillari, and F.Y. Liew Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo J. Immunol. 148 4 1992 1176 1181
20. B.K. al-Ramadi, E. Adeghate, N. Mustafa, A.S. Ponery, and M.J. Fernandez-Cabezudo Cytokine expression by attenuated intracellular bacteria regulates the immune response to infection: the Salmonella model Mol. Immunol. 38 12-13 2002 931 940
21. L. Steidler, K. Robinson, L. Chamberlain, K.M. Schofield, E. Remaut, R.W. Le Page, and J.M. Wells Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 recombinant strains of Lactococcus lactis co-expressing antigen and cytokine Infect. Immun. 66 7 1998 3183 3189
22. L. Steidler In situ delivery of cytokines by genetically engineered Lactococcus lactis Antonie Van Leeuwenhoek 82 2002 323 331
23. L.C. Chew, T.M. Ramseier, D.M. Retallack, J.C. Shneider, C.H. Squires, and H.W. Talbot Production of recombinant proteins Gerd Gellissen Novel Microbial and Eucaryotic Expression Systems 2005 Wiley-VCH Berlag Bmbh and Co. KGAA Weinheim 45 65
24. F.H.Gaertner, S.L. Lee, R.W. Shutter, Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant, and vaccine accelerant. US. Patent 20040146484 (2004).
25. J. Sambrook, E.F. Fitsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 2nd ed. 1989 Cold Spring Harbour Laboratory Press Cold Spring Harbour, NY 1.53 1.58
26. H. Bielefeldt Ohmann, and L.A. Babiuk Effect of bovine recombinant alphaI interferon on inflammatory responses of bovine phagocytes J. Interf. Res. 4 1984 249 263
27. R. Pontarollo, R. Rankin, L.A. Babiuk, D.L. Godson, P.J. Griebel, R. Hecker, A.M. Krieg, and S. van Drunen Littel-van den Hurk Monocytes are required for optimal in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs Vet. Immunol. Immunopathol. 84 1-2 2002 43 59
28. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature (London) 227 5259 1970 680 685
29. M.E. Baca-Estrada, D.L. Godson, H.P. Hughes, J. Van Donkersgoed, A. Van Kessel, R. Harland, D.E. Shuster, M. Daley, and L.A. Babiuk Effect of recombinant bovine interleukin-1 beta on viral/bacterial pneumonia in cattle J. Interferon Cytokine Res. 15 5 1995 431 439
30. D.L. Godson, M.E. Baca-Estrada, A.G. Van Kessel, H.P. Hughes, M.A. Morsy, J. Van Donkersgoed, R.J. Harland, D.E. Shuster, M.J. Daley, and L.A. Babiuk Regulation of bovine acute phase responses by recombinant interleukin-1 beta Can. J. Vet. Res. 59 4 1995 249 255
31. G. Mutwiri, T. Bowersock, A. Kidane, M. Sanchez, V. Gerdts, L.A. Babiuk, and P. Griebel Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres Vet. Immunol. Immunopathol. 87 3-4 2002 269 276
32. H. Bielefeldt Ohmann, and L.A. Babiuk Alteration of some leukocyte functions following in vivo and in vitro exposure to recombinant bovine alpha- and gamma-interferon J. Interf. Res. 6 2 1986 123 136
33. E.A. Bach, M. Aguet, and R.D. Schreiber The IFN gamma receptor: a paradigm for cytokine receptor signaling Annu. Rev. Immunol. 15 1977 563 591
34. D.L. Godson Serum haptoglobin as an indicator of the acute phase response in bovine respiratory disease Vet. Immunol. Immunopathol. 51 3-4 1996 277 292
35. H. Schellekens Follow-on biologics: challenges of the "next generation" Nephrol. Dial. Transplant. 20 suppl 4 2005 31 36
36. R. Dummer, W. Muller, F. Nestle, J. Wiede, J. Dues, W. Lechner, I. Haubitz, W. Wolf, E. Bill, and G. Burg Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients Cancer 67 9 1991 2300 2304
37. O. Prummer, C. Fiehn, and H. Gallati Anti-interferon-gamma antibodies in a patient undergoing interferon-gamma treatment for systemic mastocytosis J. Interferon Cytokine Res. 16 7 1996 519 522
38. J.A. Quiroga, I. Castillo, J.C. Porres, S. Casado, F. Saez, M. Gracia Martinez, M. Gomez, L. Inglada, L. Sanchez-Sicilia, and A. Mora Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients Hepatology 12 Pt 1 1990 661 663
39. M. Nakamura, T. Manser, G.D. Pearson, M.J. Daley, and M.L. Gefter Effect of IFN-γ on the immune response in vivo and on gene expression in vitro Nature 307 5949 1984 381 382
40. J.H. Playfair, and J.B. de Souza Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice Clin. Exp. Immunol. 67 1 1987 5 10
41. K. Takehara, K. Kobayashi, R. Ruttanapumma, M. Kamikawa, T. Nagata, Y. Yokomizo, and M. Nakamura Adjuvant effect of chicken interferon-gamma for inactivated Salmonella enteritidis antigen J. Vet. Med. Sci. 65 12 2003 1337 1341
42. D.M. Estes, N.M. Closser, and G.K. Allen IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen Cell Immunol. 154 1 1994 287 295
43. G. Sonnenfeld, D. Mandel, and T.C. Merigan The immunosuppressive effect of type II mouse interferon preparations on antibody production Cell Immunol. 34 2 1977 193 206
44. S. Zeuzem, C. Welsch, and E. Hermann Pharmokinetics of peginterferons Semin. Liver Dis. 23 2003 23 28
45. J.E. Gretz, C.C. Norbury, A.O. Anderson, A.E. Proudfoot, and S. Shaw Lymph borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironment in lymph node cortex J. Exp. Med. 192 10 2000 1425 1439